Harding Loevner LP Thermo Fisher Scientific Inc. Transaction History

Harding Loevner LP

  • $14.4 Billion
  • Q2 2025

A detailed history of Harding Loevner LP transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Harding Loevner LP holds 229,531 shares of TMO stock, worth $125 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
229,531
Previous 416,581 44.9%
Holding current value
$125 Million
Previous $207 Million 55.1%
% of portfolio
0.65%
Previous 1.65%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$390.26 - $489.06 $73 Million - $91.5 Million
-187,050 Reduced 44.9%
229,531 $93.1 Million
Q1 2025

May 15, 2025
SELL
$497.6 - $606.74 $29 Million - $35.4 Million
-58,359 Reduced 12.29%
416,581 $207 Million
Q4 2024

Feb 14, 2025
SELL
$501.29 - $612.85 $46.9 Million - $57.3 Million
-93,562 Reduced 16.46%
474,940 $247 Million
Q3 2024

Nov 14, 2024
BUY
$531.86 - $624.21 $1.46 Million - $1.71 Million
2,742 Added 0.48%
568,502 $352 Million
Q2 2024

Aug 14, 2024
SELL
$541.52 - $599.02 $10.5 Million - $11.7 Million
-19,456 Reduced 3.32%
565,760 $313 Million
Q1 2024

May 15, 2024
SELL
$528.82 - $599.43 $22.7 Million - $25.7 Million
-42,839 Reduced 6.82%
585,216 $340 Million
Q4 2023

Feb 14, 2024
SELL
$431.41 - $532.94 $5.02 Million - $6.2 Million
-11,639 Reduced 1.82%
628,055 $333 Million
Q3 2023

Nov 14, 2023
BUY
$498.29 - $574.41 $93.1 Million - $107 Million
186,928 Added 41.29%
639,694 $324 Million
Q2 2023

Aug 14, 2023
SELL
$508.46 - $591.13 $43.4 Million - $50.5 Million
-85,424 Reduced 15.87%
452,766 $236 Million
Q1 2023

May 15, 2023
BUY
$535.0 - $604.82 $3.95 Million - $4.46 Million
7,378 Added 1.39%
538,190 $310 Million
Q4 2022

Feb 14, 2023
BUY
$484.71 - $571.37 $28.4 Million - $33.5 Million
58,654 Added 12.42%
530,812 $292 Million
Q3 2022

Nov 14, 2022
SELL
$507.19 - $604.49 $14.1 Million - $16.8 Million
-27,793 Reduced 5.56%
472,158 $239 Million
Q2 2022

Aug 15, 2022
SELL
$500.9 - $612.21 $7.05 Million - $8.61 Million
-14,068 Reduced 2.74%
499,951 $272 Million
Q1 2022

May 16, 2022
SELL
$524.0 - $644.92 $73 Million - $89.8 Million
-139,260 Reduced 21.32%
514,019 $267 Million
Q4 2021

Feb 14, 2022
SELL
$569.0 - $667.24 $7.61 Million - $8.93 Million
-13,378 Reduced 2.01%
653,279 $436 Million
Q3 2021

Nov 15, 2021
SELL
$509.53 - $609.78 $1.17 Million - $1.41 Million
-2,306 Reduced 0.34%
666,657 $381 Million
Q2 2021

Aug 16, 2021
BUY
$441.0 - $508.24 $36.7 Million - $42.3 Million
83,211 Added 14.21%
668,963 $337 Million
Q1 2021

May 17, 2021
SELL
$439.85 - $518.83 $21.1 Million - $24.8 Million
-47,882 Reduced 7.56%
585,752 $267 Million
Q4 2020

Feb 16, 2021
BUY
$435.06 - $527.66 $4.8 Million - $5.82 Million
11,036 Added 1.77%
633,634 $295 Million
Q3 2020

Nov 16, 2020
BUY
$359.77 - $441.52 $9.64 Million - $11.8 Million
26,788 Added 4.5%
622,598 $275 Million
Q2 2020

Aug 14, 2020
BUY
$275.2 - $362.34 $164 Million - $216 Million
595,750 Added 992916.69%
595,810 $216 Million
Q3 2017

Nov 14, 2017
BUY
$171.74 - $194.04 $10,304 - $11,642
60
60 $11,000

Others Institutions Holding TMO

# of Institutions
2,850
Shares Held
345M
Call Options Held
3.67M
Put Options Held
3.42M
View Full List

About THERMO FISHER SCIENTIFIC INC.

TMO Quotes by TradingView
  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $213B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Harding Loevner LP Portfolio

Follow Harding Loevner LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harding Loevner LP, based on Form 13F filings with the SEC.

News

Stay updated on Harding Loevner LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email